LRA Shares Tremendous Loss of Lupus Research Hero Dr. Marc Chevrier
February 10, 2021
The worldwide lupus community lost a brilliant researcher and a passionate champion with the recent passing of...
News
Putting Out the Fire – Celebrating A Lupus “Firefighter” During Black History Month
February 4, 2021
“Imagine that your house is on fire and someone inside started it - that’s lupus,” says Dr....
New CDC Study Estimates 204,295 Americans Have Lupus
January 29, 2021
According to a new analysis funded by the Centers for Disease Control and Prevention, about 204,295 Americans...
Lupus Research Alliance Hails Approval of Aurinia’s Lupkynis(TM) (voclosoporin)
First Oral Treatment for Lupus Nephritis;
Second Lupus Treatment to Receive FDA Approval in Past Month
NEW YORK, NY. January...
Update from LRA’s President on COVID-19 Vaccines in Lupus
January 14, 2020
Dear Friends,
Happy New Year! On behalf of all of us at the Lupus Research Alliance (LRA), thank...
Vaccines and Lupus: What to Know Amid COVID-19
January 14, 2021
LRA's President and CEO Kenneth Farber taped this video series - Vaccines and Lupus: What to Know...
Lupus Advocacy Delivers Again!
December 28, 2020
After much back and forth, last week the U.S. Congress passed the year-end spending deal, called the...
LRA Pleased to Share GSK’s Benlysta® (belimumab) is First Lupus Nephritis Treatment Approved by FDA
NEW YORK, NY. December 17, 2020. The Lupus Research Alliance (LRA) congratulates GSK on the U.S. Food and Drug...
Over Half of People with Lupus Would Take COVID-19 Vaccine, Shows LRA Survey
Updated January 4, 2021
New York, NY– December 16, 2020. More than half of people with lupus (54%) are willing...
Existing Cancer Drug May Lower Inflammation in Autoimmune Diseases Like Lupus
December 14, 2020
In a recent study published in the Journal of Immunology, LRA-funded researcher Dr. John Zhang at Medical...
New Survey Shows Education and Communication Gaps in Lupus Nephritis Care
1 in 2 Lupus Nephritis Patients Don’t Know They Have Lupus
New York, NY– December 7, 2020. Significant gaps in...
LRA’s 2020 LMTA Grantees Focus on Finding Targets for New Lupus Drug Development
NEW YORK, NY. December 3, 2020 - The Lupus Research Alliance is proud to announce the 2020 recipients of...